{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:07:18Z","timestamp":1792292838121,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02552-7","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T18:02:41Z","timestamp":1665597761000},"page":"1559-1564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of the use of anti-glaucoma medications on the risk of herpetic keratitis recurrence"],"prefix":"10.1007","volume":"43","author":[{"given":"Bonnie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyar","family":"Etminan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Shokoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Iovieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia N.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"2552_CR1","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.1038\/nrdp.2016.67","volume":"2","author":"RN Weinreb","year":"2016","unstructured":"Weinreb RN, Leung CK, Crowston JG et al (2016) Primary open-angle glaucoma. Nat Rev Dis Primers 2:16067. https:\/\/doi.org\/10.1038\/nrdp.2016.67","journal-title":"Nat Rev Dis Primers"},{"key":"2552_CR2","doi-asserted-by":"publisher","first-page":"13762","DOI":"10.1038\/s41598-021-92971-w","volume":"11","author":"N Zhang","year":"2021","unstructured":"Zhang N, Wang J, Li Y, Jiang B (2021) Prevalence of primary open angle glaucoma in the last 20 years a meta-analysis and systematic review. Sci Rep 11:13762. https:\/\/doi.org\/10.1038\/s41598-021-92971-w","journal-title":"Sci Rep"},{"key":"2552_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/OPTH.S44708","volume":"8","author":"K Inoue","year":"2014","unstructured":"Inoue K (2014) Managing adverse effects of glaucoma medications. Clin Ophthalmol 8:903\u2013913. https:\/\/doi.org\/10.2147\/OPTH.S44708","journal-title":"Clin Ophthalmol"},{"key":"2552_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/ICU.0b013e32835c8aba","volume":"24","author":"Z Anwar","year":"2013","unstructured":"Anwar Z, Wellik SR, Galor A (2013) Glaucoma therapy and ocular surface disease: current literature and recommendations. Curr Opin Ophthalmol 24:136\u2013143. https:\/\/doi.org\/10.1097\/ICU.0b013e32835c8aba","journal-title":"Curr Opin Ophthalmol"},{"key":"2552_CR5","first-page":"775","volume":"75","author":"E Dios Castro","year":"2000","unstructured":"Dios Castro E, Maquet Dusart JA (2000) Latanoprost-associated recurrent herpes simplex keratitis. Arch Soc Esp Oftalmol 75:775\u2013778","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2552_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0301-4738.21617","volume":"54","author":"MT Kothari","year":"2006","unstructured":"Kothari MT, Mehta BK, Asher NS, Kothari KJ (2006) Recurrence of bilateral herpes simplex virus keratitis following bimatoprost use. Indian J Ophthalmol 54:47\u201348. https:\/\/doi.org\/10.4103\/0301-4738.21617","journal-title":"Indian J Ophthalmol"},{"key":"2552_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0002-9394(01)01360-5","volume":"133","author":"DM Kroll","year":"2002","unstructured":"Kroll DM, Schuman JS (2002) Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol 133:401\u2013403. https:\/\/doi.org\/10.1016\/S0002-9394(01)01360-5","journal-title":"Am J Ophthalmol"},{"key":"2552_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0002-9394(99)00050-1","volume":"127","author":"M Wand","year":"1999","unstructured":"Wand M, Gilbert CM, Liesegang TJ (1999) Latanoprost and herpes simplex keratitis. Am J Ophthalmol 127:602\u2013604. https:\/\/doi.org\/10.1016\/S0002-9394(99)00050-1","journal-title":"Am J Ophthalmol"},{"key":"2552_CR9","first-page":"348","volume":"27","author":"VM Villegas","year":"2008","unstructured":"Villegas VM, Diaz L, Izquierdo NJ (2008) Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report. P R Health Sci J 27:348","journal-title":"P R Health Sci J"},{"key":"2552_CR10","first-page":"585","volume":"28","author":"JM Hill","year":"1987","unstructured":"Hill JM, Shimomura Y, Dudley JB et al (1987) Timolol induces HSV-1 ocular shedding in the latently infected rabbit. Invest Ophthalmol Vis Sci 28:585\u2013590","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2552_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00003226-200403000-00004","volume":"23","author":"T Deai","year":"2004","unstructured":"Deai T, Fukuda M, Hibino T, Higaki S, Hayashi K, Shimomura Y (2004) Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications. Cornea 23:125\u2013128","journal-title":"Cornea"},{"key":"2552_CR12","unstructured":"White M, Chodosh J (2014) Herpes Simplex Virus Keratitis: A Treatment Guideline - 2014. https:\/\/www.aao.org\/clinical-statement\/herpes-simplex-virus-keratitis-treatment-guideline. Accessed October 10, 2021"},{"key":"2552_CR13","first-page":"2403","volume":"60","author":"S Shokoohi","year":"2019","unstructured":"Shokoohi S, Iovieno A, Etminan M, Yeung S (2019) Effect of topical anti-glaucoma drugs on the incidence of herpetic simplex keratitis. Invest Ophthalmol Vis Sci 60:2403","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2552_CR14","first-page":"4396","volume":"44","author":"GW Bean","year":"2003","unstructured":"Bean GW, Reardon G (2003) Association between herpes simplex keratitis and topical ocular hypotensive therapy. Invest Ophthalmol Vis Sci 44:4396","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2552_CR15","unstructured":"Government of British Columbia. (2021) 2020 Sub-Provincial Population Estimates Highlights. https:\/\/www2.gov.bc.ca\/assets\/gov\/data\/statistics\/people-population-community\/population\/pop_subprovincial_population_highlights.pdf. Accessed August 2 2021"},{"key":"2552_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2147\/COPD.S290805","volume":"16","author":"T Bahremand","year":"2021","unstructured":"Bahremand T, Etminan M, Roshan-Moniri N, De Vera MA, Tavakoli H, Sadatsafavi M (2021) Are COPD prescription patterns aligned with guidelines? Evidence from a Canadian population-based study. Int J Chron Obstruct Pulmon Dis 16:751\u2013759. https:\/\/doi.org\/10.2147\/COPD.S290805","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2552_CR17","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2147\/COPD.S210897","volume":"14","author":"H Tavakoli","year":"2019","unstructured":"Tavakoli H, Johnson KM, FitzGerald JM et al (2019) Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada. Int J Chron Obstruct Pulmon Dis 14:2003\u20132013. https:\/\/doi.org\/10.2147\/COPD.S210897","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2552_CR18","unstructured":"Ahmad B, Patel BC (2019) Herpes Simplex Keratitis. [Updated 2022 May 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545278\/"},{"key":"2552_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fimmu.2020.00766","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Wang R, Xu C, Zhou H (2020) Pathogenesis of herpes stromal keratitis: immune inflammatory response mediated by inflammatory regulators. Front Immunol 11:766","journal-title":"Front Immunol"},{"key":"2552_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jtos.2018.10.002","volume":"17","author":"AM Lobo","year":"2019","unstructured":"Lobo AM, Agelidis AM, Shukla D (2019) Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation. Ocul Surf 17:40\u201349","journal-title":"Ocul Surf"},{"key":"2552_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/OPTH.S80475","volume":"11","author":"TN Azher","year":"2017","unstructured":"Azher TN, Yin X, Tajfirouz D, Huang AJ, Stuart PM (2017) Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol 11:185\u2013191. https:\/\/doi.org\/10.2147\/OPTH.S80475","journal-title":"Clin Ophthalmol"},{"key":"2552_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/ICU.0000000000000491","volume":"29","author":"JY Li","year":"2018","unstructured":"Li JY (2018) Herpes zoster ophthalmicus: acute keratitis. Curr Opin Ophthalmol 29:328\u2013333","journal-title":"Curr Opin Ophthalmol"},{"key":"2552_CR23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1136\/bjo.85.8.1007a","volume":"85","author":"P Ekatomatis","year":"2001","unstructured":"Ekatomatis P (2001) Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma. Br J Ophthalmol 85:1008\u20131009. https:\/\/doi.org\/10.1136\/bjo.85.8.1007a","journal-title":"Br J Ophthalmol"},{"key":"2552_CR24","unstructured":"Soomro MZ, Moin M, Attaulla I. (2011) Latanoprost and herpetic keratitis. 27:226\u2013227"},{"key":"2552_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0002-9394(01)01012-1","volume":"132","author":"J Morales","year":"2001","unstructured":"Morales J, Shihab ZM, Brown SM, Hodges MR (2001) Herpes simplex virus dermatitis in patients using latanoprost. Am J Ophthalmol 132:114\u2013116. https:\/\/doi.org\/10.1016\/S0002-9394(01)01012-1","journal-title":"Am J Ophthalmol"},{"key":"2552_CR26","unstructured":"Manna B, Visalakshi S, Sudha N, Raju NJ (2018) Bimatoprost and Herpetic Keratitis-A Rare Association. 17(3):47\u201348. Ver.15 March, Chicago"},{"key":"2552_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/108076803321908356","volume":"19","author":"YJ Gordon","year":"2003","unstructured":"Gordon YJ, Yates KA, Mah FS, Romanowski EG (2003) The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models. J Ocul Pharmacol Ther 19:233\u2013245. https:\/\/doi.org\/10.1089\/108076803321908356","journal-title":"J Ocul Pharmacol Ther"},{"key":"2552_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0002-9394(00)00910-7","volume":"131","author":"HE Kaufman","year":"2001","unstructured":"Kaufman HE, Varnell ED, Toshida H, Kanai A, Thompson HW, Bazan NG (2001) Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. Am J Ophthalmol 131:643\u2013646. https:\/\/doi.org\/10.1016\/S0002-9394(00)00910-7","journal-title":"Am J Ophthalmol"},{"key":"2552_CR29","first-page":"387","volume":"29","author":"Y Haruta","year":"1988","unstructured":"Haruta Y, Rootman DS, Hill JM (1988) Recurrent HSV-1 corneal epithelial lesions induced by timolol iontophoresis in latently infected rabbits. Invest Ophthalmol Vis Sci 29:387\u2013392","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2552_CR30","first-page":"678","volume":"30","author":"DS Rootman","year":"1989","unstructured":"Rootman DS, Hill JM, Haruta Y, Reidy JJ, Kaufman HE (1989) Trifluridine decreases ocular HSV-1 recovery, but not herpetic lesions after timolol iontophoresis. Invest Ophthalmol Vis Sci 30:678\u2013683","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2552_CR31","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1167\/iovs.10-7108","volume":"52","author":"Q Fan","year":"2011","unstructured":"Fan Q, Teo Y, Saw S (2011) Application of Advanced Statistics in Ophthalmology. Invest Ophthalmol Vis Sci 52:6059\u20136065. https:\/\/doi.org\/10.1167\/iovs.10-7108","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2552_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2415-14-43","volume":"14","author":"J Cao","year":"2014","unstructured":"Cao J, Yang Y, Yang W et al (2014) Prevalence of infectious keratitis in Central China. BMC Ophthalmol 14:1\u20136","journal-title":"BMC Ophthalmol"},{"key":"2552_CR33","doi-asserted-by":"crossref","unstructured":"Song X, Xie L, Tan X et al. (2014) A multi-center, cross-sectional study on the burden of infectious keratitis in China. 9:e113843","DOI":"10.1371\/journal.pone.0113843"},{"key":"2552_CR34","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/archopht.1989.01070020221029","volume":"107","author":"TJ Liesegang","year":"1989","unstructured":"Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM (1989) Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107:1155\u20131159","journal-title":"Arch Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02552-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02552-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02552-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T15:04:40Z","timestamp":1682867080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02552-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02552-7","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. This study was performed in line with the principles of the Declaration of Helsinki. Approval for the study was obtained by the University of British Columbia\u2019s Clinical Research Ethics Board (H19-01404).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}